Omega Diagnostics's total assets for Q2 2024 were £13.50M, a decrease of -2.81% from the previous quarter. DE:RVKA total liabilities were £3.96M for the fiscal quarter, a -5.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.